Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thompson, A.
Right arrow Articles by Wall, R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thompson, A.
Right arrow Articles by Wall, R
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

The promoter and 5' flanking sequences controlling human B29 gene expression

AA Thompson, WJ Wood , MJ Gilly, MA Damore, SA Omori and R Wall

Department of Pediatrics, Gwynne Hazen Cherry Memorial Laboratories, Los Angeles, CA, USA.

The product of the B-cell-specific B29 gene (B29, Ig beta, CD79b) is essential for Ig-mediated B-cell activation via the B-cell antigen receptor complex (BCR) on human and murine B lymphocytes. To better understand the regulation of this pivotal gene, we have analyzed the human genomic DNA sequence upstream of the B29 ATG start codon for transcriptional control activity. The human B29 gene lacks either a TATA or a CAAT box and transcription is initiated at multiple sites. The minimal promoter of the human B29 gene is contained within a 193-bp region 5' of these multiple start sites. This minimal promoter exhibits B-cell-specific activity and contains SP1, ETS, OCT, and IKAROS/LYF-1 transcription factor motifs. All these motifs are strikingly conserved in sequence and placement relative to the previously characterized murine B29 promoter. Additional upstream gene segments dramatically affected B29 minimal promoter activity. A newly identified motif called the B29 conserved sequence (BCS), found upstream of both human and murine B29 promoters, appears to stimulate B29 transcription through a novel mechanism. A single BCS had little effect either on the minimal B29 promoter or on a heterologous promoter. Instead, the BCS stimulated transcription by counteracting 5' negative regulatory DNA sequences that block the activity of the B29 minimal promoter in its absence. These findings indicate that B29 gene expression is controlled by the complex interplay of positive and negative regulatory elements.

Volume 87, Issue 2, pp. 666-673, 01/15/1996
Copyright © 1996 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
E. J. Yoo, I. Cajiao, J.-S. Kim, A. P. Kimura, A. Zhang, N. E. Cooke, and S. A. Liebhaber
Tissue-Specific Chromatin Modifications at a Multigene Locus Generate Asymmetric Transcriptional Interactions
Mol. Cell. Biol., August 1, 2006; 26(15): 5569 - 5579.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Gisler and M. Sigvardsson
The Human V-PreB Promoter Is a Target for Coordinated Activation by Early B Cell Factor and E47
J. Immunol., May 15, 2002; 168(10): 5130 - 5138.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. S. Malone, M. D. Miner, J. R. Doerr, J. P. Jackson, S. E. Jacobsen, R. Wall, and M. Teitell
CmC(A/T)GG DNA methylation in mature B cell lymphoma gene silencing
PNAS, August 10, 2001; (2001) 181206898.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Gisler, S. E. W. Jacobsen, and M. Sigvardsson
Cloning of human early B-cell factor and identification of target genes suggest a conserved role in B-cell development in man and mouse
Blood, August 15, 2000; 96(4): 1457 - 1464.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. Lauring and M. S. Schlissel
Distinct Factors Regulate the Murine RAG-2 Promoter in B- and T-Cell Lines
Mol. Cell. Biol., April 1, 1999; 19(4): 2601 - 2612.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
P. Akerblad, M. Rosberg, T. Leanderson, and M. Sigvardsson
The B29 (Immunoglobulin beta -Chain) Gene Is a Genetic Target for Early B-Cell Factor
Mol. Cell. Biol., January 1, 1999; 19(1): 392 - 401.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. S. Malone, S. A. Omori, and R. Wall
Silencer elements controlling the B29 (Igbeta ) promoter are neither promoter- nor cell-type-specific
PNAS, November 11, 1997; 94(23): 12314 - 12319.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. A. Thompson, J. A. Talley, H. N. Do, H. L. Kagan, L. Kunkel, J. Berenson, M. D. Cooper, A. Saxon, and R. Wall
Aberrations of the B-Cell Receptor B29 (CD79b) Gene in Chronic Lymphocytic Leukemia
Blood, August 15, 1997; 90(4): 1387 - 1394.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. S. Malone, M. D. Miner, J. R. Doerr, J. P. Jackson, S. E. Jacobsen, R. Wall, and M. Teitell
CmC(A/T)GG DNA methylation in mature B cell lymphoma gene silencing
PNAS, August 28, 2001; 98(18): 10404 - 10409.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1996 by American Society of Hematology         Online ISSN: 1528-0020